Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-national, Multicentre, Non-interventional Study to Evaluate the Long Term Safety of Esmya, in Particular Endometrial Safety, and the Current Prescription and Management Patterns of Esmya in a Long Term Treatment Setting.

NCT02748460 is registered in ClinicalTrials.gov with PregLem SA as lead sponsor.

NCT NCT02748460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02748460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-national, Multicentre, Non-interventional Study to Evaluate the Long Term Safety of Esmya, in Particular Endometrial Safety, and the Current Prescription and Management Patterns of Esmya in a Long Term Treatment Setting.
Lead sponsor
PregLem SA
Phase
Observational
Overall status
Completed
Start date
December 22, 2015
Completion date
April 11, 2024
Enrollment
1,527 (actual)
Sites
115

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids